Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1.
Cheung, M., Kuntz, K.W., Pobanz, M., Salovich, J.M., Wilson, B.J., Andrews, C.W., Shewchuk, L.M., Epperly, A.H., Hassler, D.F., Leesnitzer, M.A., Smith, J.L., Smith, G.K., Lansing, T.J., Mook, R.A.(2008) Bioorg Med Chem Lett 18: 6214-6217
- PubMed: 18929484 
- DOI: https://doi.org/10.1016/j.bmcl.2008.09.100
- Primary Citation of Related Structures:  
3EOC - PubMed Abstract: 
The synthesis and biological activities of imidazo[5,1-f][1,2,4]triazin-2-amines (imidazotriazines) as novel polo-like kinase 1 inhibitors are reported.
Organizational Affiliation: 
GlaxoSmithKline, Fire Moore Drive, Research Triangle Park, NC 27709, USA. mui.h.cheung@gsk.com